Neurotransmitters are chemical messengers that have excitatory, inhibitory, and modulatory actions. Learn what they are and ...

Melatonin MT1 receptor plays a crucial role in regulating REM sleep. A novel drug could extend REM sleep without negative ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

The neurotransmitter travels across a tiny gap, called a synapse, to either an adjacent neuron (where it triggers an electrical charge to continue passing the message) or the receptor on a target cell ...

Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...

Visual hallucinations affect up to 75% of Parkinson’s patients, causing them to see people and animals that aren’t really there. Now, medication that targets these hallucinations, through a different ...

The neurotransmitter travels across a tiny gap, called a synapse, to either an adjacent neuron (where it triggers an electrical charge to continue passing the message) or the receptor on a target ...

Many advances in molecular neuroscience have stemmed from Dr. Snyder's identification of receptors for neurotransmitters and drugs and elucidation of the actions of psychotropic agents. He pioneered ...

A recent study from the Research Institute at McGill University Health Center may improve the treatment of sleep disorders ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...